(Q43555115)

24 November 2017

title

The cost of managing HIV infection in highly treatment-experienced, HIV-infected adults in France (English)

1 reference

24 November 2017

0 references

Dominique Costagliola

3

1 reference

24 November 2017

Xavier Colin

1

1 reference

24 November 2017

Antoine Lafuma

2

1 reference

24 November 2017

Jean-Marie Lang

4

1 reference

24 November 2017

Pascal Guillon

5

1 reference

24 November 2017

publication date

1 January 2010

1 reference

24 November 2017

1 reference

24 November 2017

volume

28 Suppl 1

1 reference

24 November 2017

page(s)

59-68

1 reference

Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F11587450-000000000-00000

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587450-000000000-00000

The survival benefits of AIDS treatment in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587450-000000000-00000

The CD4 lymphocyte count and risk of clinical progression

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587450-000000000-00000

HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587450-000000000-00000

The impact of disease stage on direct medical costs of HIV management: a review of the international literature

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587450-000000000-00000

Durable efficacy of tipranavir-ritonavir in combination with an optimised background regimen of antiretroviral drugs for treatment-experienced HIV-1-infected patients at 48 weeks in the Randomized Evaluation of Strategic Intervention in multi-drug r

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587450-000000000-00000

Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587450-000000000-00000

Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587450-000000000-00000

Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-2: 24-week results from a randomised, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587450-000000000-00000

Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587450-000000000-00000

British HIV Association guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587450-000000000-00000

Pathogenesis of HIV infection: total CD4+ T-cell pool, immune activation, and inflammation

21 January 2018

1 reference

12 December 2020

Risk of AIDS and death at given HIV-RNA and CD4 cell count, in relation to specific antiretroviral drugs in the regimen

1 reference

12 December 2020

Use and cost of antiretrovirals in France 1995-2000: an analysis based on the Medical Dossier on Human Immunodeficiency (release 2) database

1 reference

12 December 2020

Distribution of health care expenditures for HIV-infected patients

1 reference

12 December 2020

10.2165/11587450-000000000-00000

Identifiers

DOI

1 reference

Dimensions Publication ID

24 November 2017

1031004515

0 references

1 reference